English
  1. Home
  2. Stocks
  3. Syncomf Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Syncom Formulation (India)

    Small Cap
    ₹13.58
    +0.14 (1.04%)
    18 May, 2024 14:27 BSE: 524470 NSE: SYNCOMFISIN: INE312C01025

    Start SIP in Syncom Formulation (India)

    Start SIP

    Syncom Formulation (India) Performance

    Day Range

    • Low 13
    • High 14
    ₹ 13

    52 Week Range

    • Low 6
    • High 19
    ₹ 13
    • Open Price14
    • Previous Close13
    • Volume1203215

    Syncom Formulation (India) Share Price

    • Over 1 Month +7.35%
    • Over 3 Month -10.48%
    • Over 6 Month +36.35%
    • Over 1 Year +111.53%

    Syncom Formulation (India) Key Statistics

    P/E Ratio 50.4
    PEG Ratio 1.9
    Market Cap Cr 1,277
    Price to Book Ratio 4.4
    EPS 0.2
    Dividend 0
    Relative Strength Index 51.41
    Money Flow Index 42.89
    MACD Signal 0.08
    Average True Range 0.55
    Syncom Formulation (India) Financials
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 7363625961
    Operating Expenses Qtr Cr 6457565355
    Operating Profit Qtr Cr 97666
    Depreciation Qtr Cr 11111
    Interest Qtr Cr 11111
    Tax Qtr Cr 22222
    Net Profit Qtr Cr 76648
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 271239
    Operating Expenses Annual Cr 231205
    Operating Profit Annual in Cr 2820
    Depreciation Cr 55
    Interest Annual Cr 43
    Tax Annual Cr 86
    Net Profit Annual Cr 2420
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr -610
    Cash from Investing Activity Annual Cr 84-45
    Cash from Financing Annual Activity Cr -1535
    Net Cash Flow Annual Cr 1
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 286256
    Fixed Assets Annual Cr 120116
    Total Non Current Assets Annual Cr 129196
    Total Current Assets Annual Cr 263181
    Total Assets Annual Cr 392377
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 33
    ROE Annual % 88
    ROCE Annual % 1211
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1615
    Sign Up to Know More
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 7565646061
    Operating Expenses Qtr Cr 6558575355
    Operating Profit Qtr Cr 97666
    Depreciation Qtr Cr 11111
    Interest Qtr Cr 11111
    Tax Qtr Cr 32222
    Net Profit Qtr Cr 77748
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 277239
    Operating Expenses Annual Cr 234205
    Operating Profit Annual in Cr 3020
    Depreciation Cr 55
    Interest Annual Cr 43
    Tax Annual Cr 97
    Net Profit Annual Cr 2520
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr -611
    Cash from Investing Activity Annual Cr 83-45
    Cash from Financing Annual Activity Cr -1535
    Net Cash Flow Annual Cr 1
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 288256
    Fixed Assets Annual Cr 12069
    Total Non Current Assets Annual Cr 130196
    Total Current Assets Annual Cr 275182
    Total Assets Annual Cr 405378
    Sign Up to Know More
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 33
    ROE Annual % 98
    ROCE Annual % 1311
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 1615
    Sign Up to Know More
    Invest in Syncom Formulation (India)

    Syncom Formulation (India) Technicals

    EMA & SMA

    Current Price
    ₹13.58
    +0.14 (1.04%)
    • Bullish Moving Average
    • ___
    • 0
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹13.38
    • 50 Day
    • ₹13.39
    • 100 Day
    • ₹13.17
    • 200 Day
    • ₹12.08
    • 20 Day
    • ₹13.51
    • 50 Day
    • ₹12.99
    • 100 Day
    • ₹14.21
    • 200 Day
    • ₹11.82

    Syncom Formulation (India) Resistance and Support

    PIVOT
    ₹13.54
    Resistance
    First Resistance 13.73
    Second Resistance 14.01
    Third Resistance 14.21
    RSI 51.41
    MFI 42.89
    MACD Single Line 0.08
    MACD 0.07
    Support
    First Support 13.25
    Second Support 13.05
    Third Supoort 12.77

    Syncom Formulation (India) Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 2,617,654 169,519,273 64.76
    Week 2,258,225 137,029,069 60.68
    1 Month 2,416,462 155,378,522 64.3
    6 Month 6,842,023 373,848,128 54.64

    Syncom Formulation (India) Result Highlights

    Syncom Formulation (India) Synopsis

    NSE-Medical-Diversified

    Syncom Formul. is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 224.64 Cr. and Equity Capital is Rs. 94.00 Cr. for the Year ended 31/03/2023. Syncom Formulation (India) Ltd. is a Public Limited Listed company incorporated on 21/06/1988 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1988PLC047759 and registration number is 047759.
    Market Cap 1,260
    Sales 258
    Shares in Float 46.06
    No of funds 3
    Yield 1.01
    Book Value 4.39
    U/D Vol ratio 0.8
    LTDebt / Equity
    Alpha 0.19
    Beta 1.45

    Syncom Formulation (India) Shareholding Pattern

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 50.57%50.57%50.57%50.57%
    Mutual Funds
    Foreign Portfolio Investors 0.08%
    Individual Investors 44.85%44.82%44.76%45%
    Others 4.5%4.61%4.67%4.43%

    Syncom Formulation (India) Management

    Name Designation
    Mr. Kedarmal Shankarlal Bankda Exe.Chairman & W T D
    Mr. Vijay Shankarlal Bankda Managing Director
    Mrs. Rinki Ankit Bankda Whole Time Director
    Mr. Krishna Das Neema Independent Director
    Mr. Praveen Jindal Independent Director
    Mr. Vinod Kumar Kabra Independent Director
    Mrs. Ruchi Jindal Independent Woman Director
    Mr. Ritesh Kumar Lunkad Addnl.Independent Director
    Mr. Ankit Jain Addnl.Independent Director

    Syncom Formulation (India) Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Syncom Formulation (India) Corporate Action

    Date Purpose Remarks
    2024-05-17 Audited Results
    2024-02-14 Quarterly Results
    2023-11-08 Quarterly Results
    2023-08-14 Quarterly Results
    2023-05-29 Audited Results

    Syncom Formulation (India) MF Shareholding

    Name Amount(cr)

    Syncom Formulation (India) FAQs

    What is Share Price of Syncom Formulation (India) ?

    Syncom Formulation (India) share price is ₹13 As on 18 May, 2024 | 14:13

    What is the Market Cap of Syncom Formulation (India) ?

    The Market Cap of Syncom Formulation (India) is ₹1276.5 Cr As on 18 May, 2024 | 14:13

    What is the P/E ratio of Syncom Formulation (India) ?

    The P/E ratio of Syncom Formulation (India) is 50.4 As on 18 May, 2024 | 14:13

    What is the PB ratio of Syncom Formulation (India) ?

    The PB ratio of Syncom Formulation (India) is 4.4 As on 18 May, 2024 | 14:13

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.